Table 2. Correlation of clinical, laboratory, and core set variables with MRI parameters.
| Characteristics | MRI synovial hypertrophy score | MRI cartilage lesion score | MRI bone erosion score | MRI bone marrow edema score |
| Duration of disease (year) | -0.199 | 0.078 | 0.198 | 0 |
| Number of joints affected | 0.448 | -0.206 | -0.366 | 0.104 |
| Restriction of shoulder joint movement | 0.115 | 0.256 | -0.042 | 0.247 |
| Duration of early morning stiffness | -0.119 | -0.092 | -0.343 | -0.038 |
| Visual Analog Scale | 0.196 | -0.443 | -0.253 | 0.343 |
| Physician global assessment of disease activity | 0.218 | -0.372 | -0.153 | 0.265 |
| Parent/patient assessment of overall wellbeing | 0.149 | -0.486 | -0.296 | 0.357 |
| JADAS 27 | 0.217 | -0.429 | -0.246 | 0.272 |
| Erythrocyte sedimentation rate (mm/1st h) | 0.110 | -0.234 | -0.002 | -0.153 |
| C-reactive protein (mg/L) | 0.15 | -0.034 | -0.143 | 0.182 |
| Disease activity as per Wallace criteria | 1.000 | 1.000 | 0.117 | 0.587 |
| MRI: Magnetic resonance imaging; JADAS: Juvenile Arthritis Disease Activity Score. | ||||